Cara Therapeutics

$14.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-0.66%) Today
$0.00 (0.00%) As of 5:37 AM EST after-hours

Why Robinhood?

You can buy or sell CARA and other stocks, options, and ETFs commission-free!

About CARA

Cara Therapeutics, Inc. Common Stock, also called Cara Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT. The listed name for CARA is Cara Therapeutics, Inc. Common Stock.

CEO
Derek T. Chalmers
Employees
67
Headquarters
Stamford, Connecticut
Founded
2004
Market Cap
744.99M
Price-Earnings Ratio
Dividend Yield
Average Volume
437.55K
High Today
$15.19
Low Today
$14.85
Open Price
$15.06
Volume
154.22K
52 Week High
$26.67
52 Week Low
$8.88

Collections

CARA Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 25, After Hours

You May Also Like